Cerence Inc SEC Filings

Cerence Inc. (CRNC) executive vice president and chief administrative officer reported acquiring 242,044 shares of common stock on 11/21/2025 at $10.35 per share. These shares reflect achieved performance stock units (PSUs) under the company’s fiscal 2025 plan that are scheduled to vest in November 2027.

Following this transaction, the officer beneficially owns 588,333 shares of Cerence common stock in direct ownership. The filing is made on Form 4 by a single reporting person and documents an equity-based compensation event rather than an open-market purchase.

Cerence Inc. (CRNC) reported an insider equity award for its CFO. On 11/21/2025, the chief financial officer acquired 166,821 shares of Cerence common stock at $10.35 per share, increasing beneficial ownership to 443,552 shares held directly. The filing explains that this grant represents achieved performance stock units under the FY25 plan, which are scheduled to vest in November 2027. This ties the executive’s compensation more closely to the company’s longer-term performance.

Cerence Inc. (CRNC) reported an equity award to its EVP and Chief Revenue Officer on a Form 4. On 11/21/2025, the executive acquired 49,905 shares of common stock at a price of $10.35 per share, reported as an acquired transaction. Following this award, the executive beneficially owns 161,780 shares of Cerence common stock in direct ownership.

The filing notes that this grant represents achieved performance stock units (PSUs) under the company’s FY25 plan, which are scheduled to vest in November 2027. This reflects part of the executive’s performance-based compensation structure tied to company goals over the fiscal 2025 period.

Cerence Inc. (CRNC)49,905 shares of Cerence common stock at $10.35 per share. After this transaction, the executive beneficially owns 254,886 shares directly.

The company notes this grant represents performance stock units (PSUs) achieved under the FY25 plan that are scheduled to vest in November 2027, tying the award to longer-term performance and retention.

Cerence Inc. (CRNC) reports fiscal 2025 revenue of $251.8 million, down 24% from $331.5 million a year earlier, reflecting softer demand and a shift in its business mix. The company posted a much smaller net loss of $18.7 million for the year ended September 30, 2025, compared with a net loss of $588.1 million in fiscal 2024.

Cerence remains a major player in automotive conversational and generative AI, with its technologies shipped in more than 525 million vehicles to date and an estimated 52% of all cars produced in fiscal 2025 including its solutions. As of September 30, 2025, it reported estimated five-year backlog of $1,169.2 million, including $165.2 million of remaining performance obligations and $1,004.0 million of variable backlog, up from $952.7 million a year earlier.

The company is restructuring through its 2024 and 2025 plans to reduce operating expenses and focus on profitable growth, while continuing to invest heavily in R&D and cloud-connected AI offerings for global automakers and tier-one suppliers.

Cerence Inc. (CRNC) filed a current report to announce that it has released its financial results for the fiscal year ended September 30, 2025. The company distributed a detailed press release, attached as Exhibit 99.1, and an earnings release investor presentation, attached as Exhibit 99.2, to discuss its full-year performance. Both exhibits include non-GAAP financial measures along with explanations of these metrics and reconciliations to GAAP figures, giving investors additional ways to review the company’s results. The materials are furnished under Item 2.02 of the report and are not treated as filed for liability purposes.

Cerence Inc. announced a resolution of its patent disputes with Samsung through a cross‑license agreement. As part of the settlement, Samsung agreed to pay Cerence a one‑time lump sum of $49,500,000.

The agreement resolves two cases: “Samsung I,” filed October 13, 2023, and “Samsung II,” filed March 15, 2024. Samsung had asserted counterclaims in July 2024, and trials had been scheduled for October 2025 and April 2026. The cross‑license, reached on October 28, 2025, concludes the litigation path and provides Cerence with a defined cash inflow in place of uncertain trial outcomes.

Brian M. Krzanich, a Director and the Chief Executive Officer of Cerence Inc. (CRNC), reported a disposition of 132,075 shares of common stock on 10/09/2025 at a reported sale price of $11.4585 per share. After the reported transaction, the reporting person beneficially owned 905,987 shares. The filing explains the sale represented a mandatory "sell to cover" to satisfy tax withholding for vested restricted stock units and was not a discretionary trade by the reporting person. The Form 4 was signed on 10/10/2025 by an attorney-in-fact.

Jennifer Salinas, EVP Chief Admin Officer of Cerence Inc. (CRNC), reported two sales of company common stock. On 10/06/2025 she sold 64,784 shares at $12.7573 to satisfy tax withholding required by the company’s RSU sell-to-cover policy. The following day, on 10/07/2025, she sold 77,994 shares at $12.3122 under a pre-established Rule 10b5-1 trading plan adopted on 02/11/2025. After the transactions her reported direct beneficial ownership is 346,289 shares. The filings include a signature dated 10/07/2025 and state the sales were procedural (tax withholding and an existing trading plan) rather than discretionary trades.